Skip to content

Pasadena Star News

70°F
Tuesday, April 14th 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

17.63 +0.80 (+4.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 606,890
Open 16.90
Bid (Size) 17.62 (100)
Ask (Size) 17.63 (2,600)
Prev. Close 16.83
Today's Range 16.83 - 17.70
52wk Range 10.96 - 21.48
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
From CareDx, Inc.
Via Business Wire

Performance

YTD
-7.9%
-7.9%
1 Month
+1.8%
+1.8%
3 Month
-14.3%
-14.3%
6 Month
+21.3%
+21.3%
1 Year
-6.7%
-6.7%

More News

Read More
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
CareDx Inc (NASDAQ:CDNA) Reports Strong Revenue Beat but Profitability Concerns Weigh on Shares ↗
Via Chartmill
News headline image
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
News headline image
Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗
Via The Motley Fool
News headline image
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
From CareDx, Inc.
Via Business Wire
News headline image
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx President and CEO Sells 19,000 Shares for $412,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Provides Notice of Proposed Derivative Settlement
From CareDx, Inc.
Via Business Wire
News headline image
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire

Frequently Asked Questions

Is CareDx, Inc. - Common Stock publicly traded?
Yes, CareDx, Inc. - Common Stock is publicly traded.
What exchange does CareDx, Inc. - Common Stock trade on?
CareDx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CareDx, Inc. - Common Stock?
The ticker symbol for CareDx, Inc. - Common Stock is CDNA on the Nasdaq Stock Market
What is the current price of CareDx, Inc. - Common Stock?
The current price of CareDx, Inc. - Common Stock is 17.63
When was CareDx, Inc. - Common Stock last traded?
The last trade of CareDx, Inc. - Common Stock was at 04/14/26 04:00 PM ET
What is the market capitalization of CareDx, Inc. - Common Stock?
The market capitalization of CareDx, Inc. - Common Stock is 927.82M
How many shares of CareDx, Inc. - Common Stock are outstanding?
CareDx, Inc. - Common Stock has 928M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.